Publicaciones en las que colabora con María Antonia Blasco Marhuenda (28)

2022

  1. A mouse model for Li-Fraumeni-Like Syndrome with cardiac angiosarcomas associated to POT1 mutations

    PLoS Genetics, Vol. 18, Núm. 6

  2. Consequences of telomere dysfunction in fibroblasts, club and basal cells for lung fibrosis development

    Nature Communications, Vol. 13, Núm. 1

2020

  1. The mTOR pathway is necessary for survival of mice with short telomeres

    Nature Communications, Vol. 11, Núm. 1

2018

  1. Therapeutic effects of telomerase in mice with pulmonary fibrosis induced by damage to the lungs and short telomeres

    eLife, Vol. 7

2010

  1. TPP1 is required for TERT recruitment, telomere elongation during nuclear reprogramming, and normal skin development in mice

    Developmental Cell, Vol. 18, Núm. 5, pp. 775-789

2009

  1. Increased telomere fragility and fusions resulting from TRF1 deficiency lead to degenerative pathologies and increased cancer in mice

    Genes and Development, Vol. 23, Núm. 17, pp. 2060-2075

  2. MSH2 deficiency abolishes the anticancer and pro-aging activity of short telomeres

    Aging Cell, Vol. 8, Núm. 1, pp. 2-17

  3. TRF1 controls telomere length and mitotic fidelity in epithelial homeostasis

    Molecular and Cellular Biology, Vol. 29, Núm. 6, pp. 1608-1625

  4. Telomere shortening relaxes X chromosome inactivation and forces global transcriptome alterations

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 106, Núm. 46, pp. 19393-19398

2008

  1. Telomerase Reverse Transcriptase Delays Aging in Cancer-Resistant Mice

    Cell, Vol. 135, Núm. 4, pp. 609-622

2007

  1. Deficient mismatch repair improves organismal fitness and survival of mice with dysfunctional telomeres

    Genes and Development, Vol. 21, Núm. 17, pp. 2234-2247

  2. Delayed ageing through damage protection by the Arf/p53 pathway

    Nature, Vol. 448, Núm. 7151, pp. 375-379

  3. Telomerase abrogation dramatically accelerates TRF2-induced epithelial carcinogenesis

    Genes and Development, Vol. 21, Núm. 2, pp. 206-220

2006

  1. Increased p53 activity does not accelerate telomere-driven ageing

    EMBO Reports, Vol. 7, Núm. 5, pp. 546-552

2005

  1. Antagonistic effects of telomerase on cancer and aging in K5-mTert transgenic mice

    Oncogene, Vol. 24, Núm. 13, pp. 2256-2270

  2. The telomerase RNA component Terc is required for the tumour-promoting effects of Tert overexpression

    EMBO Reports, Vol. 6, Núm. 3, pp. 268-274

  3. XPF nuclease-dependent telomere loss and increased DNA damage in mice overexpressing TRF2 result in premature aging and cancer

    Nature Genetics, Vol. 37, Núm. 10, pp. 1063-1071

2004

  1. Constitutive expression of tert in thymocytes leads to increased incidence and dissemination of T-cell lymphoma in Lck-tert mice

    Molecular and Cellular Biology, Vol. 24, Núm. 10, pp. 4275-4293

  2. Impact of telomerase ablation on organismal viability, aging, and tumorigenesis in mice lacking the DNA repair proteins PARP-1, Ku86, or DNA-PKcs

    Journal of Cell Biology, Vol. 167, Núm. 4, pp. 627-638

  3. Shorter telomeres, accelerated ageing and increased lymphoma in DNA-PKcs-deficient mice

    EMBO Reports, Vol. 5, Núm. 5, pp. 503-509